FEN endonucleases
View Patent ↗The present invention provides novel cleavage agents and polymerases for the cleavage and modification of nucleic acid. The cleavage agents and polymerases find use, for example, for the detection and characterization of nucleic acid sequences and variations in nucleic acid sequences. In some embodiments, the 5′ nuclease activity of a variety of enzymes is used to cleave a target-dependent cleavage structure, thereby indicating the presence of specific nucleic acid sequences or specific variations thereof.
1. A composition comprising a purified Archaeaglobus veneficus flap endonuclease-1 (FEN-1).
2. The composition of claim 1 , wherein said endonuclease comprises an amino acid sequence comprising SEQ ID NO:370.
3. The composition of claim 1 , wherein said endonuclease is encoded by a DNA sequence comprising SEQ ID NO:369.
4. A kit comprising the composition of claim 1 .
5. A composition comprising a chimerical FEN-1 endonuclease, said chimerical FEN-1 comprising at least a portion of a FEN-1 endonuclease selected from the group consisting of Sulfolobus solfataricus, Pyrobaculum aerophilum, Thermococcus litoralis, Archaeaglobus veneficus, Archaeaglobus profundus, Acidianus brierlyi, Acidianus ambivalens, Desulfurococcus amylolyticus, Desulfurococcus mobilis, Pyrodictium brockii, Thermococcus gorgonarius, Thermococcus zilligii, Methanopyrus kandleri, Methanococcus igneus, Pyrococcus horikoshii, and Aeropyrum pernix.
6. The composition of claim 5 , wherein said portion comprises a functional domain.
7. The composition of claim 5 , wherein said portion comprises a portion of a sequence selected from the group consisting of SEQ ID NOs: 337, 341, 345, 349, 353, 357, 361, 365, 370, 375, 379, 384, 389, 394, 398, and 402.
8. A mixture comprising: i) a first structure-specific nuclease selected from the group consisting of Sulfolobus solfataricus, Pyrobaculum aerophilum, Thermococcus litoralis, Archaeaglobus veneficus, Archaeaglobus profundus, Acidianus brierlyi, Acidianus ambivalens, Desulfurococcus amylolyticus, Desulfurococcus mobilis, Pyrodictium brockii, Thermococcus gorgonarius, Thermococcus zilligii, Methanopyrus kandleri, Methanococcus igneus, Pyrococcus horikoshii, and Aeropyrum pernix ; and ii) a purified second structure-specific nuclease.
9. The mixture of claim 8 , wherein said first structure-specific nuclease comprises a sequence selected from the group consisting of SEQ ID NOs: 337, 341, 345, 349, 353, 357, 361, 365, 370, 375, 379, 384, 389, 394, 398, and 402.
10. The mixture of claim 8 , wherein said purified second structure-specific nuclease comprises a structure-specific nuclease selected from the group consisting of Sulfolobus solfataricus, Pyrobaculum aerophilum, Thermococcus litoralis, Archaeaglobus veneficus, Archaeaglobus profundus, Acidianus brierlyi, Acidianus ambivalens, Desulfurococcus amylolyticus, Desulfurococcus mobilis, Pyrodictium brockii, Thermococcus gorgonarius, Thermococcus zilligii, Methanopyrus kandleri, Methanococcus igneus, Pyrococcus horikoshii, and Aeropyrum pernix.
11. The mixture of claim 8 , wherein said purified second structure-specific nuclease comprises a sequence selected from the group consisting of SEQ ID NOs: 337, 341, 345, 349, 353, 357, 361, 365, 370, 375, 379, 384, 389, 394, 398, and 402.
12. The mixture of claim 8 , wherein said second structure-specific nuclease comprises a polymerase.
13. The mixture of claim 12 , wherein said polymerase comprises a DNA polymerase.
14. The mixture of claim 13 , wherein said DNA polymerase comprises a thermostable DNA polymerase.
15. The mixture of claim 8 , wherein said second structure-specific nuclease comprises a 5′ nuclease derived from a DNA polymerase altered in amino acid sequence such that it exhibits reduced DNA synthetic activity from that of the wild-type DNA polymerase but retains substantially the same 5′ nuclease activity of the wild-type DNA polymerase.
16. The mixture of claim 15 , wherein said 5′ nuclease comprises a thermostable 5′ nuclease.
17. The mixture of claim 8 , wherein said second structure-specific nuclease is selected from the group consisting of CLEAVASE BN enzyme, CLEAVASE DA enzyme, CLEAVASE DN enzyme, CLEAVASE DV enzyme, CLEAVASE BN/thrombin enzyme, CLEAVASE TThDN enzyme, Thermus aquaticus DNA polymerase, Thermus thermophilus DNA polymerase, Escherichia coli Exo III, and Saccharomyces cerevisiae Rad1/Rad10 complex.
18. A nucleic acid treatment kit comprising:
a) a composition comprising purified FEN-1 endonuclease selected from the group consisting of Sulfolobus solfataricus, Pyrobaculum aerophilum, Thermococcus litoralis, Archaeaglobus veneficus, Archaeaglobus profundus, Acidianus brierlyi, Acidianus ambivalens, Desulfurococcus amylolyticus, Desulfurococcus mobilis, Pyrodictium brockii, Thermococcus gorgonarius, Thermococcus zilligii, Methanopyrus kandleri, Methanococcus igneus, Pyrococcus horikoshii, and Aeropyrum pernix; and
b) oligonucleotides capable of forming an invasive cleavage structure in the presence of a target nucleic acid.
19. The kit of claim 18 , wherein said oligonucleotides comprise:
a) a first oligonucleotide comprising a 5′ portion complementary to a first portion of a target nucleic acid; and
b) a second oligonucleotide comprising: a 5′ portion complementary to a second portion of said target nucleic acid downstream of and contiguous to said first portion; and a 3′ portion.
20. The kit of claim 19 , wherein said 3′ portion of said second oligonucleotide comprises a 3′ terminal nucleotide not complementary to said target nucleic acid.
21. The kit of claim 19 , wherein said 3′ portion of said second oligonucleotide consists of a single nucleotide not complementary to said target nucleic acid.
22. The kit of claim 19 , further comprising a solid support.
23. The kit of claim 22 , wherein said first oligonucleotide is attached to said solid support.
24. The kit of claim 22 , wherein said second oligonucleotide is attached to said solid support.
25. The kit of claim 19 , further comprising a buffer solution.
26. The kit of claim 25 , wherein said buffer solution comprises a source of divalent cations.
27. The kit of claim 26 , wherein said divalent cation comprises Mn 2+ .
28. The kit of claim 26 , wherein said divalent cation comprises Mg 2+ .
29. The kit of claim 19 , further comprising a third oligonucleotide complementary to a third portion of said target nucleic acid upstream of said first portion of said first target nucleic acid.
30. The kit of claim 19 , further comprising one or more target nucleic acids.